Source: Virtual Congress 2021 – Bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
P. Oscanoa Huaman (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain), R. Amaro Rodriguez (Barcelona, Spain), L. Bueno Freire (Barcelona, Spain), N. Vàzquez (Barcelona, Spain), L. Fernández-Barat (Barcelona, Spain), A. Torres Martí (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain). Diagnostic value of the Biofire® Filmarray Pneumonia panel compared to conventional sputum culture in patients with an exacerbation of bronchiectasis. 2067

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern Source: Eur Respir J, 54 (5) 1901144; 10.1183/13993003.01144-2019 Year: 2019 Diagnostic accuracy of sputum induction test compared with bronchoscopic results in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Diagnostic value of BAL lymphocytosis in patients with suspected IPF and indeterminate HRCT pattern Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Clinical significance of aspergillus isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017 Induced sputum (IS) analysis for bacterial pneumonia diagnosis in HIV positive patients Source: Eur Respir J 2003; 22: Suppl. 45, 333s Year: 2003 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Diagnostic role of micro-MGIT culture of BAL samples in sputum smear-negative pulmonary tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Role of bronchoalveolar lavage in new sputum smear negative pulmonary tuberculosis patients Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Microbiology of induced sputum vs oropharyngeal culture in cystic fibrosis patients not producers of spontaneous sputum Source: Eur Respir J 2007; 30: Suppl. 51, 647s Year: 2007 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Diagnostic importance of bronchial aspiration with protected catheter in COPD patients with unresolved community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014